|
1
|
Aljiffry M, Abdulelah A, Walsh M,
Peltekian K, Alwayn I and Molinari M: Evidence-based approach to
cholangiocarcinoma: a systematic review of the current literature.
J Am Coll Surg. 208:134–147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patel T: Worldwide trends in mortality
from biliary tract malignancies. BMC Cancer. 2:102002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martin R and Jarnagin W: Intrahepatic
cholangiocarcinoma. Current management. Minerva Chir. 58:469–478.
2003.PubMed/NCBI
|
|
4
|
de Jong MC, Nathan H, Sotiropoulos GC, et
al: Intrahepatic cholangiocarcinoma: an international
multi-institutional analysis of prognostic factors and lymph node
assessment. J Clin Oncol. 29:3140–3145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nakagohri T, Kinoshita T, Konishi M,
Takahashi S and Gotohda N: Surgical outcome and prognostic factors
in intrahepatic cholangiocarcinoma. World J Surg. 32:2675–2680.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morimoto Y, Tanaka Y, Ito T, et al:
Long-term survival and prognostic factors in the surgical treatment
for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg.
10:432–440. 2003. View Article : Google Scholar
|
|
7
|
Ohtsuka M, Ito H, Kimura F, et al: Results
of surgical treatment for intrahepatic cholangiocarcinoma and
clinicopathological factors influencing survival. Br J Surg.
89:1525–1531. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weber SM, Jarnagin WR, Klimstra D,
DeMatteo RP, Fong Y and Blumgart LH: Intrahepatic
cholangiocarcinoma: resectability, recurrence pattern, and
outcomes. J Am Coll Surg. 193:384–391. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen WF, Zhong W, Xu F, et al:
Clinicopathological and prognostic analysis of 429 patients with
intrahepatic cholangiocarcinoma. World J Gastroenterol.
15:5976–5982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li FH, Chen XQ, Luo HY, et al: Prognosis
of 84 intrahepatic cholangiocarcinoma patients. Ai Zheng.
28:528–532. 2009.(In Chinese). PubMed/NCBI
|
|
11
|
Higashi M, Yamada N, Yokoyama S, et al:
Pathobiological implications of MUC16/CA125 expression in
intrahepatic cholangiocarcinoma-mass forming type. Pathobiology.
79:101–106. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Uenishi T, Kubo S, Hirohashi K, Tanaka H,
et al: Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker
in primary liver cancer. Br J Cancer. 88:1894–1899. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tao LY, Cai L, He XD, Liu W and Qu Q:
Comparison of serum tumor markers for intrahepatic
cholangiocarcinoma and hepatocellular carcinoma. Am Surg.
76:1210–1213. 2010.PubMed/NCBI
|
|
14
|
Rana TM: Illuminating the silence:
understanding the structure and function of small RNAs. Nat Rev Mol
Cell Biol. 8:23–36. 2007. View
Article : Google Scholar
|
|
15
|
Jannot G and Simard MJ: Tumour-related
microRNAs functions in Caenorhabditis elegans. Oncogene.
25:6197–6201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen L, Yan HX, Yang W, et al: The role of
microRNA expression pattern in human intrahepatic
cholangiocarcinoma. J Hepatol. 50:358–369. 2009. View Article : Google Scholar
|
|
17
|
Karakatsanis A, Papaconstantinou I,
Gazouli M, Lyberopoulou A, Polymeneas G and Voros D: Expression of
microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c,
miR-221, miR-222, and miR-223 in patients with hepatocellular
carcinoma or intrahepatic cholangiocarcinoma and its prognostic
significance. Mol Carcinog. 52:297–303. 2013. View Article : Google Scholar
|
|
18
|
Hu C, Huang F, Deng G, Nie W, Huang W and
Zeng X: miR-31 promotes oncogenesis in intrahepatic
cholangiocarcinoma cells via the direct suppression of RASA1. Exp
Ther Med. 6:1265–1270. 2013.PubMed/NCBI
|
|
19
|
Zeng B, Li Z, Chen R, et al: Epigenetic
regulation of miR-124 by hepatitis C virus core protein promotes
migration and invasion of intrahepatic cholangiocarcinoma cells by
targeting SMYD3. FEBS Lett. 586:3271–3278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Watanabe A, Tagawa H, Yamashita J, et al:
The role of microRNA-150 as a tumor suppressor in malignant
lymphoma. Leukemia. 25:1324–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Farhana L, Dawson MI, Murshed F, Das JK,
Rishi AK and Fontana JA: Upregulation of miR-150* and
miR-630 induces apoptosis in pancreatic cancer cells by targeting
IGF-1R. PLoS One. 8:e610152013. View Article : Google Scholar
|
|
23
|
Liu H, Zhu L, Liu B, et al: Genome-wide
microRNA profiles identify miR-378 as a serum biomarker for early
detection of gastric cancer. Cancer Lett. 316:196–203. 2012.
View Article : Google Scholar
|
|
24
|
Meyer CG, Penn I and James L: Liver
transplantation for cholangiocarcinoma: results in 207 patients.
Transplantation. 69:1633–1637. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shimoda M, Farmer DG, Colquhoun SD, et al:
Liver transplantation for cholangiocellular carcinoma: analysis of
a single-center experience and review of the literature. Liver
Transpl. 7:1023–1033. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schetter AJ, Leung SY, Sohn JJ, et al:
MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ganepola GA, Rutledge JR, Suman P,
Yiengpruksawan A and Chang DH: Novel blood-based microRNA biomarker
panel for early diagnosis of pancreatic cancer. World J
Gastrointest Oncol. 6:22–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brockhausen J, Tay SS, Grzelak CA,
Bertolino P, et al: miR-181a mediates TGF-β induced hepatocyte EMT
and is dysregulated in cirrhosis and hepatocellular cancer. Liver
Int. Feb 28–2014.(Epub ahead of print). View Article : Google Scholar
|
|
30
|
Yang X, Zeng Z, Hou Y, Yuan T, Gao C, Jia
W, Yi X and Liu M: MicroRNA-92a as a potential biomarker in
diagnosis of colorectal cancer: a systematic review and
meta-analysis. PLoS One. 9:e887452014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng G, Xiong Y, Xu W, et al: A
two-microRNA signature as a potential biomarker for early gastric
cancer. Oncol Lett. 7:679–684. 2014.PubMed/NCBI
|
|
32
|
Zhou L, Qi X, Potashkin JA, Abdul-Karim FW
and Gorodeski GI: MicroRNAs miR-186 and miR-150 down-regulate
expression of the pro-apoptotic purinergic P2×7 receptor by
activation of instability sites at the 3′-untranslated region of
the gene that decrease steady-state levels of the transcript. J
Biol Chem. 283:28274–28286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Q, Jin H, Yang Z, et al: MiR-150
promotes gastric cancer proliferation by negatively regulating the
pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 392:340–345.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yokobori T, Suzuki S, Tanaka N, et al:
MiR-150 is associated with poor prognosis in esophageal squamous
cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci.
104:48–54. 2013. View Article : Google Scholar
|
|
35
|
Srivastava SK, Bhardwaj A, Singh S, et al:
MicroRNA-150 directly targets MUC4 and suppresses growth and
malignant behavior of pancreatic cancer cells. Carcinogenesis.
32:1832–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang TC, Yu D, Lee YS, et al: Widespread
microRNA repression by Myc contributes to tumorigenesis. Nat Genet.
40:43–50. 2008. View Article : Google Scholar
|
|
38
|
Nakanuma Y, Sasaki M, Sato Y, Ren X, Ikeda
H and Harada K: Multistep carcinogenesis of perihilar
cholangiocarcinoma arising in the intrahepatic large bile ducts.
World J Hepatol. 1:35–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pigati L, Yaddanapudi SC, Iyengar R, et
al: Selective release of microRNA species from normal and malignant
mammary epithelial cells. PLoS One. 5:e135152010. View Article : Google Scholar : PubMed/NCBI
|
